Jun 2, 2022
May was Bladder Cancer Awareness Month, so we wanted to share a
conversation with Dr. Yair Lotan on the state of bladder cancer
awareness and research, his work with the Bladder Cancer Advocacy
Network, and some of the advancements in bladder cancer research
that most excite him.
Dr. Lotan is a urology professor and chief of urologic oncology at
University of Texas Southwestern Medical Center in Dallas, Texas.
He’s known nationally for his research on urine markers and
molecular markers, which will help determine patients at higher
risk for recurrent cancer.
Bladder cancer is the sixth most common cancer diagnosed annually
in the U.S.,
according to the National Library of Medicine.
This is the second part of a two-part conversation we conducted
with Dr. Lotan. In the first, we discussed a micro-cost analysis
published in Urology that broke down
per-procedural costs for cystoscopy and explored how single-use
cystoscopes might provide a cost-effective option for
providers.
Dr. Lotan is an Ambu consultant.
Show notes: